SAL Farooqiq7 PD 3-Col

Total Page:16

File Type:pdf, Size:1020Kb

SAL Farooqiq7 PD 3-Col State of the art lecture Primary care: the custodian of diabetes care? Azhar Farooqi Abstract General Practitioner and Honorary Professor, Type 2 diabetes is the disease of our times. With some 3 million cases in the UK, primary care University of Leicester, East Leicester Medical Practice, has a vital role in coordinating and delivering evidence-based care which includes the Leicester, UK prevention, detection and management of diabetes. However, primary care has not always been able to deliver such a role; up to the end of the 1980s, despite the drawbacks of busy hospital outpatient clinics, primary care could rarely Correspondence to: offer the systematic care and skills that people with diabetes require. Professor Azhar Farooqi OBE, East Leicester Medical Quality improvement and audit in the 1990s heralded the increased adoption of Practice, 131 Uppingham Rd, Leicester LE5 4BP, UK; email: [email protected] evidence-based practice in primary care. Many GP practices significantly improved the organisation and quality of care for diabetes as a result. The widespread adoption of IT Received: 30 July 2012 systems and the emergence of a more robust evidence base for care (for example, UKPDS) Accepted: 1 August 2012 accelerated this process. More lately, investment in general practice through the Quality and Outcomes Framework This paper was presented as the 2012 Mary and practice education programmes have helped deliver significant improvements in the Mackinnon lecture at the 2012 Diabetes UK Annual quality of primary care diabetes. Professional Conference held in Glasgow However, there is still much to do, with variation in care and health inequalities persisting. The development of clinical commissioning offers further opportunities to make the best use of available resources and target investment where it is most likely to benefit patients. A health care system where primary care in collaboration with other stakeholders coordinates the care of people with diabetes offers the best hope in addressing this modern epidemic that we face. Copyright © 2012 John Wiley & Sons. Practical Diabetes 2012; 29(7): 286–291 Key words primary care diabetes; quality improvement; clinical commissioning; education and diabetes Introduction Background: the burden and One of the cornerstones of the challenge of diabetes National Health Service in the Type 2 diabetes is the disease of our United Kingdom is a primary care times. The UK prevalence of this system where all citizens are able to chronic condition has increased register with a doctor-led service. from an estimated 1.4 million in This service not only holds the 1998 to almost 2.6 million in 2010; central patient record, but also this is predicted to rise to 4 million offers health care from conception by 2020.3 The numbers of people to the grave. It is ideally placed with impaired glucose tolerance and to coordinate and deliver the at risk of future diabetes is estimated life-long, holistic care required by at double those with confirmed dis- people with long-term conditions ease. The financial costs of diabetes, such as diabetes. which already consume >10% of Mary Mackinnon (whose consid- the health care budget,4 are set to erable contributions to diabetes are increase with the rising numbers of well described in Richard Holt’s patients, and with the increase in Mary Mackinnon lecture of 2011)1 expensive complications such as recognised this potential over three renal failure and cardiovascular decades ago. Mary spent much of disease. The human costs of this her early career improving commu- huge burden of poor health and lost nity services for people with dia- years of life are incalculable. betes; she subsequently went on The positive side of this dim to develop and deliver pioneering picture is that, unlike 30 years ago, diabetes education for primary care we now have a robust evidence base professionals.2 It is therefore fitting on prevention, early detection (in that in this lecture I consider the the case of type 2 disease) and progress of diabetes services in management of established dis- primary care, and whether primary ease.5,6 Appropriate interventions care is indeed achieving its potential can prevent or delay the complica- to be a fit custodian for the care of tions of diabetes, and we now have people with diabetes. technologies which allow many 286 PRACTICAL DIABETES VOL. 29 NO. 7 COPYRIGHT © 2012 JOHN WILEY & SONS State of the art lecture The 2012 Mary Mackinnon lecture complications, if detected early (for 11 12 example, diabetic retinopathy) to Hayes TM, Harries J. Cardiff, UK Singh B, et al. Wolverhampton, UK be treated effectively. GP patients vs OPD Structured GP mini-clinics vs OPD These developments, which apply to a large patient group with 200 patients, 100 discharged to GP Matched pair design, n=4222 patients lifelong disease, pose a real chal- lenge on how best to organise 5-year follow up services for diabetes. A conservative estimate based on just four reviews HbA1c 9.5% (hospital) vs 10.5% (GP) 9.6% (hospital) vs 9.7% (GP) OHA or follow ups a year, means that in the UK a minimum of 12 million Higher mortality in primary care 10.6% (hospital) vs 10.8% (GP) BD insulin consultations per year are required for people with proven diabetes. Only 13% in GP seen annually Only small % of all practices ran mini-clinics While some of these patients will have complex disease or complica- Hospital care superior No difference in HbA1c after 2 years tions which require hospital-based between hospital and GP patients specialist care, it is clear that for the vast majority of patients care can GP = general practice; OPD = outpatient diabetes clinic; OHA = oral hypoglycaemic agents; only realistically be met in primary BD = twice-daily care, where general practices already deliver a doctor-led service Table 1. Should type 2 diabetes be managed in hospital or general practice? Summary of 2 papers providing 330 million face-to-face published in the British Medical Journal in 198411,12 patient consultations per year.7 The challenges for primary care, primary care. Eric Wilkes10 explored the hospital service had better gly- however, are considerable. These some of these issues further when a caemic control and lower mortality include ensuring staff have the large cohort of patients was dis- compared to those followed up in appropriate skills, support and time charged from the Sheffield hospital general practice. The study showed to deliver consistent and high service in the late 1970s. Wilkes, in a that only 13% of patients in the gen- quality diabetes services. These prospective study, demonstrated that eral practice arm attended regular challenges have increased over the many practices did not have the follow up. In contrast, a study by last three decades as diabetes has infrastructure to adequately follow Singh, Holland and Thorn,12 pub- become more common, and the up such patients. In his perceptive lished in the same journal, demon- evidence base for treatment more summary of this study, Wilkes articu- strated that patients discharged to clear. I will explore how primary lates the dilemma patients faced: selected practices which provided care has evolved to try and ensure it ‘...deaf, anxious partially sighted organised diabetes care (diabetes can deliver the services people with patients not accustomed to rapid learning mini-clinics) had outcomes which diabetes deserve. in strange hospital environments absorb were as good as hospital-based little of what they are told, but busy follow up. Interestingly, these The 1980s, the decade of GPs attuned to contractual requirements practices included those which realisation and herculean tasks in the 5-minute Thorn had worked with in the 1970s The debate as to whether diabetes consultation may not seek out extra to develop mini-clinics.9 (in particular type 2 disease) should work; even if they do, they will have to Both the Hayes and the Singh be managed in hospital by specialists pay for the detection and pursuit of studies show that the glycaemic con- or by GPs in primary care is not a non-attenders themselves.’ trol for hospital and general practice new one. Even in the 1970s when the In the 1980s, a common view patients was by today’s standard prevalence of diabetes was much (particularly among specialists) was poor, with the average HbA1c lower, questions were being asked as that general practice simply could achieved >10% (86mmol/mol). to where care was best undertaken. not be trusted to look after diabetes These and other studies provide Pioneers such as Professor John and, however imperfect, large-scale objective evidence that most general Malins recognised as far back as the hospital outpatient care was the practices at this time had neither the 1960s that crowded hospital outpa- only solution. structure, nor the organisation, to tient clinics were not best placed to In 1984 two papers, published in look after patients with diabetes provide care for many patients. the British Medical Journal, con- effectively. However, well-organised Malins in Birmingham and Thorn in tributed further to this debate practices (although still a minority) Wolverhampton did some of the (Table 1). Hayes and Harries11 pub- could deliver care equivalent to that early work to enhance the capability lished the results of a study in which provided in hospital diabetes clinics. and expertise of general practice, patients attending a hospital dia- This conclusion is further con- including assisting practices to set betes clinic were randomly allocated firmed in a meta-analysis by Griffin et up structured mini-clinics.8,9 either to continue attending hospi- al. (Figure 1).13 The difficulties of oversubscribed tal, or to receive follow-up care in The time up to and including the diabetes clinics prompted some hos- general practice.
Recommended publications
  • To View the Programme at a Glance
    Key BS Basic science Awards sessions Masterclasses Poster sessions Wednesday, 6 March 2019 CC Community care Breaks Named Lectures Sponsored symposia sessions CS Clinical science Diabetes UK professional Oral abstract sessions Symposia sessions PC Primary care interest groups Plenary sessions Workshops SC Specialist care From 7.45 Registration, exhibition and posters 8.45 –10.25 Hall 1 Opening plenary 8.45 Opening words Chris Askew, Diabetes UK Prevention and remission at scale: Paradigm shifts in Type 2 diabetes management (CC, CS, PC, SC) Chair: George Alberti, London 8.55 NHS Diabetes Prevention Programme update Jonathan Valabhji, London 9.10 Patient perspective Harry Matharu, High Wycombe 9.25 Diabetes remission: The DiRECT way Roy Taylor, Newcastle upon Tyne 9.40 Patient perspective David Paul, Warenford 9.55 Diabetes prevention: Can mass treatment be part of the strategy? Paul Aveyard, Oxford 10.10 Panel discussion 10.25 –11.05 Hall 1 Banting Memorial Lecture: The ongoing challenge of hypoglycaemia, a century after the discovery of insulin (CC, CS, PC, SC) Chair: Stephanie Amiel, London Simon Heller, Sheffield 11.05 –11.35 Coffee, exhibition, posters and Demonstration Theatre* 11.35 – Hall 1 Room 11 Hall 2L (Exhibition Hall) Room 3A Room 4 Arena (Exhibition Hall) Room 3B Room 12 12.35/13.05 11.35 –13.05 11.35 –13.05 11.35 –13.05 11.35 –12.35 11.35 –12.35 11.35 –13.05 11.35 –12.35 11.35 –12.35 Diabetic Medicine symposium: Psychological and emotional Enteral feeding with diabetes Reintegrating the Practical aspects of Audit Exercise
    [Show full text]
  • Research Project Directory Spring 2017
    Research Project Directory Spring 2017 Our research 2017-18 1 Introduction Welcome to our directory of research projects for 2017. I’m delighted to share with In 2016 we committed to supporting 35 new you the innovative research projects. I hope you enjoy reading about them we’re supporting across the and some of the other key bits of research we UK. Each project is only fund. By supporting us you’ll help us fund more possible thanks to the research in the future. continued support of our You can support research projects through our members, donors, fundraisers Adopt a Project scheme (page 6). You can also and local groups. find out more about each of the projects detailed We’ve been funding research for over 80 years, here at www.diabetes.org.uk/research awarding our first ever grant in 1935. Since then, we’ve seen some incredible steps forward in I’d like to once again thank all of our current diabetes care: the insulin pen, glucose meters, supporters – our work depends entirely on your islet transplants. We’ve supported the researchers donations. Your support is absolutely vital. behind all of these breakthroughs. Please get in touch with us at [email protected] if you have any Every year we spend around £7 million on questions, comments or suggestions about world-leading diabetes research. That makes us our research. the largest charitable funder of diabetes research in the UK. The pioneering work we fund today covers all forms of diabetes and related complications. Everything we know about managing and treating diabetes is thanks to Dr Elizabeth Robertson research.
    [Show full text]
  • 2018 Annual Report & Financial Statements(PDF
    Our story Annual report and accounts 2018 Contents Foreword 4 Our vision, mission and values 6 Our strategy 8 Our year in numbers 10 Strategic report: Knowledge is power 12 Getting together, giving support 16 Research changing lives 20 Raising standards in care 24 Preventing Type 2 diabetes 28 Making life easier 32 The fight for Flash 36 Making it happen: partnerships 40 Making it happen: volunteers 44 Making it happen: fundraisers 48 Thank you 54 Future plans 56 Get involved 58 Get support 60 Our finances and how we are run 62 Independent auditor’s report 85 Financial statements 2018 90 Foreword As we reflect on a year of huge achievement for people living with and Our own fundraising events like Swim22 and the One Million Step Challenge at risk of diabetes, a simple but important truth is powerfully clear: grew significantly in 2018, while the growth in our partnership and philanthropy together we achieve more. It’s an idea that shines through our story of fundraising has played an important part too. As always, we are indebted to 2018 time and again. every single person who has supported our work. Thank you. We’re proud to have worked alongside people with diabetes, healthcare While we reflect on our successes in 2018, we cannot shy away from how the professionals and NHS leaders, and to have joined forces with the business changing world around us affects the way we provide the support, information community and other charities. Our world-class researchers, life-changing and research that people need. At the time of writing, we continue to demand campaigners and fundraisers make it all possible and, vitally, our work that the government ensures the vital needs of people with diabetes are met continues to be inspired by people whose lives have been affected by when we leave the European Union.
    [Show full text]
  • Diabetes in Old Age THIRD EDITION
    Diabetes in Old Age THIRD EDITION Diabetes in Old Age Third Edition Edited by Alan J. Sinclair © 2009 John Wiley & Sons Ltd. ISBN: 978-0-470-06562-4 Other titles in the Wiley Diabetes in Practice Series Exercise and Sport in Diabetes Second Edition Edited by Dinesh Nagi 978 0470 022061 Complementary Therapies and the Management of Diabetes and Vascular Disease Edited by Patricia Dunning 978 0470 014585 Diabetes in Clinical Practice: Questions and Answers from Case Studies Edited by N. Katsilambros, E. Diakoumopoulou, I. Ioannidis, S. Liatis, K. Makrilakis, N. Tentolouris and P. Tsapogas 978 0470 035221 Obesity and Diabetes Second Edition Edited by Anthony Barnett and Sudhesh Kumar 9780 0470 848982 Prevention of Type 2 Diabetes Edited by Manfred Ganz 978 0470 857335 Diabetes – Chronic Complications Second Edition Edited by Kenneth Shaw and Michael Cummings 978 0470 865798 The Metabolic Syndrome Edited by Christopher Byrne and Sarah Wild 978 0470 025116 Psychology in Diabetes Care Second Edition Edited by Frank J. Snoek and T. Chas Skinner 978 0470 015049 The Foot in Diabetes Fourth Edition Edited by Andrew J. M. Boulton, Peter R. Cavanagh and Gerry Rayman 978 0470 015049 Gastrointestinal Function in Diabetes Mellitus Edited by Michael Horowitz and Melvin Samson 978 0471 899167 Diabetic Nephropathy Edited by Christopher Hasslacher 978 0471 589924 Nutritional Management of Diabetis Mellitus Edited by Gary Frost, Anne Dornhorst and David R. Hadden 978 0471 962045 Hypoglycaemia in Clinical Diabetes Second Edition Edited by Brian M. Frier and Miles Fisher 978 0470 018446 Diabetic Cardiology Edited by Miles Fisher and John McMurray 978 0470 862049 Diabetes in Old Age THIRD EDITION Editor Alan J.
    [Show full text]
  • Diabetes UK Annual Report and Accounts 2019
    our story Annual report and accounts 2019 Contents Foreword 4 Our vision, our values, our mission 6 Our strategy 8 Our year in numbers 10 Strategic report: Shining a light on mental health 12 The remission revolution 16 Life-changing advances in research 20 Reducing the risk of type 2 24 Support at every step 28 The best care for everyone 32 Partners in our vision 36 Thank you 40 Our future plans 46 Get involved 50 Get support 52 Our finances and how we’re run 54 Independent auditor’s report 78 Financial statements 2019 82 Contents Foreword Welcome to our Annual Report 2019, in which we are proud to share all that we achieved last year, and introduce you to a few of the people for whom our work made a difference. Thank you to everyone – each individual supporter, community group, philanthropic organisation and business – who has supported us to achieve so much for so many in the past 12 months. At the time of writing this introduction, we are in the midst of the coronavirus (Covid-19) pandemic. As a charity, we are meeting unprecedented levels of demand upon our services, by many thousands of people living with or near diabetes who are understandably concerned or worried or who are seeking guidance and support. At the same time as meeting the calls upon us, we are steering the charity through the impacts of loss of income and of severe disruption to our work, whilst ensuring that all our staff are supported to do their work and to look after their own health and that of their loved ones.
    [Show full text]
  • Wednesday, 14 March 2018
    Key BS Basic science Awards sessions Oral abstract sessions Sponsored symposia sessions Wednesday, 14 March 2018 CS Clinical science Diabetes UK professional Plenary sessions Symposia sessions PC Primary care interest groups Poster sessions Workshops SC Secondary care Named lectures Breaks From 7.45 Registration, exhibition and posters 8.45 –10.25 ICC Auditorium Opening plenary 8.45 Opening words Chris Askew, Diabetes UK Cardiovascular risk reduction in diabetes: Maximising patient benefits (CS, PC, SC) Chair: Naveed Sattar, Glasgow 8.55 Epidemiology: The burden of cardiovascular disease in people with diabetes – Martin Rutter, Manchester 9.13 New clinical trials: The promise of added benefit – David Preiss, Oxford 9.31 Making cardiovascular disease risk reduction happen in primary care – Tony Willis, London 9.49 A patients perspective on cardiovascular disease risk reduction in diabetes – David Garrell, Dundee 10.07 Open discussion 10.25 –10.55 ICC Auditorium Plenary session with Simon Stevens Chair: Chris Askew, Diabetes UK Simon Stevens, NHS England 10.55 –11.35 Coffee, exhibition and posters 11.35 – ICC Auditorium Rooms 8–11 Rooms 7 and 12 Rooms 3 and 4 Arena (Exhibition Hall) Room 14 Room 17 Rooms 15 and 16 12.35/13.05 11.35–13.05 11.35–13.05 11.35–12.35 11.35–12.35 11.35–12.35 11.35–13.05 11.35–13.05 11.35–12.35 Diabetes UK’s evidence based Inpatient care and the National The REPOSE trial Diabetes and cancer Weaving psychological Population health Workshop: Sponsored nutrition guidelines for the Diabetes Inpatient Audit (NaDIA) of insulin pump therapy (CS, SC) principles into routine (CS) Hypoglycaemia: symposia: prevention and management (CS, SC) vs.
    [Show full text]
  • PROJECT DIRECTORY 2016 –17 RESEARCH SPOTLIGHTS INTRODUCTION 03 Welcome to Diabetes UK’S 2016–2017 MIKE’S STORY Research Directory
    PROJECT DIRECTORY 2016 –17 RESEARCH SPOTLIGHTS INTRODUCTION 03 Welcome to Diabetes UK’s 2016–2017 MIKE’S STORY Research Directory. We’re delighted to 04 share with you the innovative studies we’re supporting across the UK. Each ADOPT A PROJECT 05 one is only possible thanks to the continued support of our members, 06 EASTERN donors and Diabetes UK groups. Everything we know about managing and treating diabetes LONDON is as a result of research. Diabetes UK awarded its first 07 research grant in 1935 and the impact of the research we’ve MIDLANDS funded over the last 85 years on people’s lives is immense. 15 For example, the first ever insulin pen, ‘Penject’, was released in 1983, designed by researchers in Glasgow and NORTH WEST 16 tested in a Diabetes UK trial involving 76 people with Type 1 diabetes. It replaced the traditional syringe and NORTHERN & YORKSHIRE influenced the pens that came after. Thanks to early 18 Diabetes UK funding, the insulin pen became an important NORTHERN IRELAND tool for people with Type 1 and Type 2 diabetes all over 21 the world. SCOTLAND We’re now the largest charitable funder of diabetes research 24 in the UK. The pioneering work we fund covers all forms of diabetes and related complications. Through research, we SOUTH EAST 28 can support the ideas and people that will transform the treatment and prevention of diabetes, and lead us to a cure. SOUTH WEST 32 Every year we spend around £7 million on new and ongoing diabetes research. In 2015 alone we committed to invest in WALES 33 new projects supporting established researchers and 25 leaders of the future.
    [Show full text]
  • Research Project Directory Spring 2018
    Research project directory Spring 2018 Our research 2018 1 Introduction Welcome to Diabetes UK’s directory of research projects for Spring 2018. I’m delighted to share with you the innovative research we’re supporting across the UK. Each project is only In 2017 alone, we supported 37 new projects possible thanks to the and committed around £7 million to world-leading continued support of our diabetes research. I hope that you enjoy reading members, donors and about the research we fund, and you might Diabetes UK groups. consider helping us fund more research in We’ve been funding the future. research for over 80 years, You can support research projects that interest awarding our first ever you through our Adopt a Project scheme (page 5). grant in 1935. Since then, To find out more about each project, go to we’ve seen some incredible steps forward in diabetes.org.uk/research. diabetes care: the insulin pen, glucose meters, I’d like to take this opportunity to personally thank islet transplants. The researchers behind these all of our current supporters. Without your donations, discoveries have all had our support. we wouldn’t be able to achieve what we do. We’re the largest charitable funder of diabetes Please get in touch with us at research in the UK. The pioneering work we fund [email protected] if you have any today covers all forms of diabetes and related questions, comments or suggestions about complications. Everything we know about our research. managing and treating diabetes is thanks to research. And through this, we want to reach a world where diabetes can do no harm.
    [Show full text]
  • Conference Program
    AASD 2020 16TH INTERNATIONAL CONFERENCE OF ARABIC ASSOCIATION FOR THE STUDY OF DIABETES AND METABOLISM الجمعية العربية لدراسة أمراض السكر والميتابوليزم MEMBER OF INTERNATIONAL DIABETES FEDERATION, IDF 28 – 31 OCTOBER, 2020, EGYPT VIRTUAL MEETING Guest of Honor Prof Andrew JM Boulton IDF President AASD & Conference Honorary President Prof Raafat Rashwan AASD & Conference President Prof Inass Shaltout AASD & Conference Vice-President Prof Amr Abdel Wahab Conference Vice-President Prof Mohamed Hassanein Conference is accredited with 20 hours By (CEMTA) 1 AASD 2020 Guest of Honor IDF President Prof Andrew JM Boulton AASD & Conference Honorary President Prof Raafat Rashwan AASD & Conference President Prof Inass Shaltout AASD & Conference Vice-President Prof Amr Abdel Wahab Conference Vice-President Prof Mohamed Hassanein 2 Conference & AASD Secretary Prof Omar El-Saadany Prof Abdel Khalek Hamed Prof Hazem El Ashmawy Scientific Committee Chairmen Prof Amr Elmeligi Prof Ashraf Attia Prof Atef Elbahry Prof Mohamed Naguieb Prof Shereen Abdel Ghaffar Prof Yasser Abdel Hamid Dr Nader Wadie Scientific Committee Moderators AASD Treasure Dr Mazen Attia Dr Hisham Habib Dr. Sayed Gad 3 16TH International Conference of Arabic Association for the Study of Diabetes and Metabolism (AASD) Member of International Diabetes Federation, IDF Dear professors and colleagues, It gives us a great pleasure to welcome you in 16th annual virtual AASD conference. On behalf of AASD board and members, we appreciate the strong participation and support of International Diabetes Federation, IDF. AASD as a member of IDF puts a great responsibility on all AASD members to do extra efforts for the cause of Diabetes. Let me express our gratitude to prof Andrew Boulton, president of the International Diabetes Federation and guest of honor of AASD conference 2020 for his extraordinary support of all AASD activities.
    [Show full text]